09:44 AM EDT, 08/20/2024 (MT Newswires) -- Amgen ( AMGN ) said Tuesday that Otezla is now available in the US for the treatment of moderate to severe plaque psoriasis in patients aged six to 17.
The company said the US Food and Drug Administration has not approved any other oral medications for the treatment of the disease in this age group.
Price: 328.95, Change: +0.98, Percent Change: +0.30